Rehmann Capital Advisory Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$35.4K Hold
1,601
﹤0.01% 728
2019
Q2
$33.1K Buy
1,601
+615
+62% +$14.2K ﹤0.01% 981
2019
Q1
$28.4K Sell
986
-900
-48% -$22.2K ﹤0.01% 1002
2018
Q4
$32.3K Sell
1,886
-515
-21% -$12.5K ﹤0.01% 728
2018
Q3
$68.3K Buy
2,401
+21
+0.9% +$693 0.01% 696
2018
Q2
$79.9K Sell
2,380
-80
-3% -$2.49K 0.01% 627
2018
Q1
$60K Buy
+2,460
New +$49K 0.01% 692
2013
Q4
Sell
-5,060
Closed -$208K 316
2013
Q3
$208K Sell
5,060
-246
-5% -$10.3K 0.07% 252
2013
Q2
$245K Buy
+5,306
New +$238K 0.09% 204

Other funds holding THC

Rehmann Capital Advisory Group's THC Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Tenet Healthcare (THC) position steady in Q3 2019 at 1,601 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Rehmann Capital Advisory Group first reported a position in THC in Q2 2013 and has held it in 9 quarters since. The position peaked at $245K in Q2 2013. 246 funds tracked by Wall St. Rank hold THC as of Q3 2019.

  • Rehmann Capital Advisory Group held 1,601 shares of Tenet Healthcare worth $35.4K as of Q3 2019.
  • Rehmann Capital Advisory Group left its Tenet Healthcare share count unchanged in Q3 2019.
  • Tenet Healthcare made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #728 holding.
  • Rehmann Capital Advisory Group first reported a position in Tenet Healthcare in Q2 2013 and has held it in 9 quarters since.
  • Rehmann Capital Advisory Group's Tenet Healthcare position peaked at $245K in Q2 2013.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.